MedWatch

Results: 721



#Item
51HealthCore contracts with Harvard Pilgrim Health Care Institute as part of institute’s $150 million FDA Sentinel award Wilmington, DE—Oct. 14, 2014—HealthCore, Inc. the clinical outcomes-based research subsidiary f

HealthCore contracts with Harvard Pilgrim Health Care Institute as part of institute’s $150 million FDA Sentinel award Wilmington, DE—Oct. 14, 2014—HealthCore, Inc. the clinical outcomes-based research subsidiary f

Add to Reading List

Source URL: healthcore.com

Language: English - Date: 2014-10-14 14:30:56
52February 14, 2014  Agila Specialties Private Limited Initiates Voluntary Nationwide Recall of 10 Lots of Etomidate Injection 2 mg/mL - 10 mL and 20 mL due to the Presence of Particulate Matter and/or Illegible and Missin

February 14, 2014 Agila Specialties Private Limited Initiates Voluntary Nationwide Recall of 10 Lots of Etomidate Injection 2 mg/mL - 10 mL and 20 mL due to the Presence of Particulate Matter and/or Illegible and Missin

Add to Reading List

Source URL: files.shareholder.com

Language: English
53FDA’s investigation into patients being injected with simulated IV fluids continues [Updated: [removed]FDA and the Centers for Disease Control and Prevention (CDC) are continuing to investigate multiple instances of W

FDA’s investigation into patients being injected with simulated IV fluids continues [Updated: [removed]FDA and the Centers for Disease Control and Prevention (CDC) are continuing to investigate multiple instances of W

Add to Reading List

Source URL: www.mass.gov

Language: English - Date: 2015-01-21 14:32:43
54MedSun Newsletter - January 2015 Articles: Alere INRatio2 PT/INR Professional Test Strips: Recall FDA MedWatch Safety Alert Alere Inc. initiated a voluntary correction to inform U.S. users of the Alere INRatio and INRati

MedSun Newsletter - January 2015 Articles: Alere INRatio2 PT/INR Professional Test Strips: Recall FDA MedWatch Safety Alert Alere Inc. initiated a voluntary correction to inform U.S. users of the Alere INRatio and INRati

Add to Reading List

Source URL: www.fda.gov

Language: English
55Office of Surveillance and Epidemiology

Office of Surveillance and Epidemiology

Add to Reading List

Source URL: www.fda.gov

Language: English
56SAXENDA® (liraglutide [rDNA origin] injection)

SAXENDA® (liraglutide [rDNA origin] injection)

Add to Reading List

Source URL: www.fda.gov

Language: English
57BEACON NEWSLETTER TEAM  November 2012 LT COL SHARON WILLIAMS LT COL VAN DON WILLIAMS

BEACON NEWSLETTER TEAM November 2012 LT COL SHARON WILLIAMS LT COL VAN DON WILLIAMS

Add to Reading List

Source URL: www.capmembers.com

Language: English - Date: 2012-11-05 13:07:01
58Consumer Health Information www.fda.gov/consumer Magic Power Coffee: POTENTIALLY DANGEROUS­

Consumer Health Information www.fda.gov/consumer Magic Power Coffee: POTENTIALLY DANGEROUS­

Add to Reading List

Source URL: permanent.access.gpo.gov

Language: English - Date: 2013-04-24 11:30:34
59MEDICAL NECESSITY GUIDELINE DEPARTMENT: Pharmacy DOCUMENT NAME: Brand Name Override PAGE: 1 of 5 REFERENCE NUMBER: CP.PMN.22

MEDICAL NECESSITY GUIDELINE DEPARTMENT: Pharmacy DOCUMENT NAME: Brand Name Override PAGE: 1 of 5 REFERENCE NUMBER: CP.PMN.22

Add to Reading List

Source URL: www.nhhealthyfamilies.com

Language: English - Date: 2014-09-12 09:01:59
60Food and Drug Administration Office of the Commissioner / Office of Planning Risk Communication Staff SUMMARY MINUTES RISK COMMUNICATION ADVISORY COMMITTEE (RCAC)

Food and Drug Administration Office of the Commissioner / Office of Planning Risk Communication Staff SUMMARY MINUTES RISK COMMUNICATION ADVISORY COMMITTEE (RCAC)

Add to Reading List

Source URL: www.fda.gov

Language: English